MedX Health Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA5850901037
CAD
0.06
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About MedX Health Corp. stock-summary
stock-summary
MedX Health Corp.
Pharmaceuticals & Biotechnology
MedX Health Corp. is a medical device company. The Company is focused on research, development, manufacturing and distribution of phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode (LED). Its products are offered to the rehabilitation market for treating pain, tissue damage, swelling and inflammation. It offers SIAscopy, which is a medical device that is used to scan suspicious moles and lesions. Its SIMSYS-MoleMate Skin Imaging System is a non-invasive skin screening procedure for moles and lesions. Its SIMSYS uses SIAscopy providing detail and information from approximately two millimeters beneath the skin. Its MoleMate is a non-invasive, rapid and painless screening device that has been designed with and for general practitioners and skin specialists. Its SIAMETRICS allows cosmetic formulators and active ingredient manufacturers to measure and quantify the concentrations of melanin, hemoglobin and collagen in living human skin.
Company Coordinates stock-summary
Company Details
1495 Bonhill Road, Unit 1 , MISSISSAUGA ON : L5T1M2
stock-summary
Tel: 1 905 6704428
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert von der Porten
Chairman of the Board
Mr. Scott Spearn
President, Chief Executive Officer, Director
Mr. Wayne Cockburn
Director
Mr. Steven Guillen
Director
Mr. Anthony Milonas
Director
Mr. N. Gary Van Nest
Director
Mr. David Hennigar
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 18 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.81

stock-summary
Return on Equity

53.60%

stock-summary
Price to Book

-2.01